Programmed death-1 and its ligand are novel immunotolerant molecules expressed on leukemic B cells in chronic lymphocytic leukemia.
Programmed death-1 (PD-1) is an immunoreceptor predominantly expressed on exhausted T cells, which through an interaction with its ligand (PD-L1), controls peripheral tolerance by limiting effector functions of T lymphocytes. qRT-PCR for PD-1, PD-L1 and their splicing forms as well as flow cytometri...
Main Authors: | Maciej Grzywnowicz, Joanna Zaleska, Daniel Mertens, Waldemar Tomczak, Paulina Wlasiuk, Kamila Kosior, Agnieszka Piechnik, Agnieszka Bojarska-Junak, Anna Dmoszynska, Krzysztof Giannopoulos |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22532845/?tool=EBI |
Similar Items
-
Peptide vaccination induces profound changes in the immune system in patients with B-cell chronic lymphocytic leukemia
by: Michael Schmitt, et al.
Published: (2011-04-01) -
Expression of HLA-G in patients with B-cell chronic lymphocytic leukemia (B-CLL).
by: M Schmitt, et al.
Published: (2009-01-01) -
Th17/IL-17A might play a protective role in chronic lymphocytic leukemia immunity.
by: Iwona Hus, et al.
Published: (2013-01-01) -
Prognostic Value of Tie2-Expressing Monocytes in Chronic Lymphocytic Leukemia Patients
by: Justyna Woś, et al.
Published: (2021-06-01) -
Aberrant Expression of <i>TLR2</i>,<i> TLR7</i>, <i>TLR9</i>, Splicing Variants of <i>TLR4</i> and <i>MYD88</i> in Chronic Lymphocytic Leukemia Patients
by: Katarzyna Skorka, et al.
Published: (2021-02-01)